Introduction
Zika virus (ZIKV) is a mosquito-transmitted flavivirus in the family Flaviviridae. During the past decade, ZIKV has moved from the status of an obscure arthropod-borne virus (arbovirus) of little public health importance to the position of a Public Health Emergency of International Concern (PHEIC).1–3 Apart from reports of sexual and congenital transmission in humans, the primary transmission cycle of ZIKV is thought to involve primates (nonhuman as well as human) and certain species of Aedes mosquitoes.1,2 The available data indicate that there are two cycles of ZIKV; a sylvan cycle involving nonhuman primates and forest-dwelling mosquitoes, and an urban/suburban cycle involving humans and Aedes aegypti and, to a lesser extent, Aedes albopictus.1,2 In this regard, the sylvan and urban cycles of ZIKV are similar to those described for dengue virus (DENV), yellow fever virus (YFV), and chikungunya virus, the three other arboviral pathogens that are also transmitted by Ae. aegypti in their urban cycles.4–6
Since the declaration of the current Zika epidemic as a PHEIC, ZIKV research has focused mainly on the pathogenesis, genetics, molecular biology, and structure of the virus, with the goal of developing improved diagnostic methods, vaccines, therapeutics, and effective methods of disease prevention.3 In contrast, much less research effort has been directed at the mosquito component of the ZIKV life cycle, specifically factors affecting vector competence, transmission efficiency, and long-term maintenance of the virus.
One of the basic questions that has long puzzled arbovirologists is how arboviruses persist during adverse environmental conditions (cold periods in temperate regions and hot dry seasons in tropical zones) when adult vectors, such as mosquitoes, are absent or in very low numbers.7 Vertical (transovarial or transovum) transmission (VT) of a virus from female insects directly to their progeny is one mechanism for arbovirus maintenance in nature during adverse environmental conditions. VT can also maintain a virus in a specific locality, when most of the potential vertebrate hosts are immune, either as a result of vaccination or natural infection. There is both field and laboratory evidence that many arboviruses are vertically transmitted in their natural arthropod vectors, including some of the major flaviviruses such as DENV, YFV, Japanese encephalitis virus (JEV), St. Louis encephalitis virus (SLEV), West Nile virus (WNV), and tick-borne encephalitis virus.7 There is also evidence that many of the insect-specific nonpathogenic flaviviruses are also maintained by VT in their natural mosquito hosts.8,9
Given this background, we undertook laboratory studies to determine if ZIKV is vertically transmitted in Ae. aegypti and Ae. albopictus. This report describes results of our preliminary studies, demonstrating that ZIKV is vertically transmitted by infected Ae. aegypti females to some of their progeny, thus providing a potential mechanism for the virus to be maintained during adverse climatic conditions.
Materials and Methods
Mosquitoes.
Two established laboratory colonies of Ae. aegypti and Ae. albopictus at the University of Texas Medical Branch were used in this study. The progenitors of the Ae. aegypti colony were originally obtained from Bangkok, Thailand; the progenitors of the Ae. albopictus colony were originally collected in Maracaibo, Venezuela. Both colonies were determined to be free of insect-specific viruses (ISVs) by culture in C6/36 cells, next-generation sequencing, and transmission electron microscopy, since previous studies8,9 have shown that some mosquito laboratory colonies are infected with ISVs that may reduce the infectivity and replication of a second heterologous flavivirus by superinfection exclusion. Mosquitoes were reared in an insectary, maintained at 27°C with 80% relative humidity and a 16-hour light/8-hour dark photoperiod.
Virus.
The virus used in the experiments was ZIKV strain MEX I-44. This virus was originally isolated from a pool of Ae. aegypti mosquitoes collected in Chiapas, Mexico, in December 2015 and had been passaged three times in Vero cells.
Infection of mosquitoes.
Approximately 100 female mosquitoes of each species were inoculated intrathoracically10 with a ZIKV stock containing 106 plaque forming units (PFU)/mL. Infected mosquitoes were held in screened cages (BioQuip Products, Gardena, CA) within a plastic glove box at 27°C and maintained on 10% sucrose solution. Ten days after infection, mosquitoes were fed defibrinated sheep blood, using a Hemotek membrane feeding system (Discovery Workshops, Accrington, United Kingdom), as per manufacturer's instructions. After feeding, approximately 50 blood-engorged females were removed from the cage and transferred into four cylindrical 5-L cardboard containers with fine netting on top, each containing a 50-mL beaker holding moist paper toweling for oviposition.10 Cotton balls saturated with 10% sucrose solution were placed on top of the containers as an energy source. Six days after the blood meal, when many eggs were present on the moist paper, it was removed from the cage and dried for storage. Ten of the surviving female mosquitoes of both species were removed from the cages and frozen for subsequent titration.
Virus assay on mosquitoes.
Eggs from the first oviposition of the infected Ae. aegypti and Ae. albopictus females were hatched and the emerging larvae reared to adults, using standard procedures10 in an insectary maintained at 27°C. The F1 adult offspring from the infected parents were collected and frozen at −80°C. Frozen F1 adult mosquitoes were subsequently thawed and sorted into pools of 25 insects (both sexes) each. Mosquito pools were then homogenized in 1.0 mL phosphate-buffered saline, pH 7.4, containing 20% fetal bovine serum with penicillin (100 U/mL) and streptomycin (100 mg), using a TissueLyser (Qiagen, Hilden, Germany). After centrifugation at 10,000 rpm for 10 minutes, the supernatant was passed through a 0.20-μm nylon syringe filter (Fisher Scientific, Pittsburgh, PA); then 150 μL of each supernatant filtrate was inoculated into separate 12.5-cm2 flask cultures of C6/36 cells, originally obtained from the American Type Culture collection (Manassas, VA). After 2 hours of absorption at 28°C, 5.0 mL of maintenance medium was added to each flask. Cultures were held in an incubator at 28°C for 7 days. On the seventh day, some of the cells were scraped from the plastic surface, and spotted onto Cel-Line 12-well glass slides (Thermo Fisher Scientific, Waltham, MA) for examination by indirect fluorescent antibody technique (IFAT),11 using a specific mouse hyperimmune polyclonal antibody prepared against ZIKV strain MR 766, obtained from the World Reference Center for Emerging Viruses and Arboviruses.
RNA extraction and quantitative real-time reverse transcription polymerase chain reaction.
RNA extraction from the ZIKV-infected parent female mosquitoes was performed using a combination of TRIzol reagent (Life Technologies) and Qiagen protocols, as we have previously optimized the combination of these protocols to yield high-quality and high-integrity RNA.12 After extraction, all RNA samples were quantified spectrophotometrically using a NanoDrop ND-1000 (NanoDrop Technologies, Thermo Fisher Scientific). A real-time primer/probe set specific for ZIKV MR766 (Prototype, Uganda, 1947, GenBank accession no. AY632535)13 was synthesized by IDT Technologies (Coralville, IA) with 5′FAM as a reporter dye for the probe. Quantitative and reverse transcription polymerase chain reaction (RT-PCR) steps were performed with iScript One-Step RT-PCR Kit for Probes (Bio-Rad, Hercules, CA) using the manufacturer's protocol and an iCycler (Bio-Rad). For absolute quantification, a standard curve was constructed with 10-fold dilutions of RNA extracted from a sample of known infectivity of 2.03 × 106 PFU determined by plaque assay in Vero E6 cells. Amplification efficiency of the reaction was 100.7% with a correlation coefficient of 0.99. A linear equation was generated by plotting the threshold cycle (CT) values of the standard curve and the log of the viral concentration. Viral load CT values from the mosquito samples were determined by real-time PCR and converted to log10 PFU equivalents per mosquito, using the linear equation determined for the standard curve.12
Results
Virus load in parent females.
Ten of the parent female mosquitoes of each species (Ae. aegypti and Ae. albopictus) were frozen for testing 10 days after infection with ZIKV and 6 days after their first blood meal (total of 16 days postinfection). Each mosquito was tested individually by RT-PCR, as described above, and the viral load was calculated as log10 PFU per insect. The mean virus titer in the 10 Ae. aegypti females was 6.13 log10 PFU/mosquito (standard deviation [STDEV] = 0.57 log10). Mean virus titer in the 10 Ae. albopictus females was 6.35 log10 PFU/mosquito (STDEV = 0.45 log10).
Testing F1 progeny for ZIKV infection.
A total of 69 pools consisting of 1,738 F1 adult Ae. aegypti were tested. Six of the 69 pools were IFAT-positive (Figure 1), indicating that one or more of the F1 progeny in the pool were infected with ZIKV. Based on these results, we estimated a minimum ZIKV filial infection rate of 1:290 for the experimentally infected Ae. aegypti. None of the 32 Ae. albopictus pools, comprising 803 adults, were positive in the IFAT.
Discussion
The observation that ZIKV was vertically transmitted by infected Ae. aegypti females to some of their F1 offspring is not unexpected, in view of the results of other studies of VT with flavivirus pathogens in their mosquito vectors.14–27 Table 1 summarizes the results of selected published studies of VT of nine flavivirus pathogens by mosquitoes. In these studies, the parent female mosquitoes were infected by intrathoracic inoculation; although this is not a natural route of infection, the technique insures that all of the females are infected. In contrast, infection of mosquitoes by the oral route requires high titers of virus and the results are more variable. However, even in experiments in which 100% of the parent females were infected, the filial infection rates in their F1 offspring varied widely, depending upon the mosquito species and geographic strain used, the virus type and strain used, the mosquito developmental stage tested (immature or adult), the virus assay method, the larval rearing temperature, the interval between initial infection and the first blood meal, and the ovarian cycle of F1 offspring examined.14–27 For example, several studies16,17,20,22,25 have compared the filial infection rates of DENV, JEV, or SLEV in multiple geographic strains of a single mosquito species (i.e., Ae. aegypti, Ae. albopictus, or Culex quinquefasciatus) and have reported marked differences in the infection rates of their F1 progeny. Similarly, other studies16,22–24 have compared the filial infection rates among different mosquito species after infection with a single flavivirus type. Alternatively, other studies16,17,22,26 have compared filial infection rates in a single mosquito colony experimentally infected with multiple strains of a single flavivirus type. In each case, considerable variation was observed in filial infection rates among F1 progeny of the infected female parents. Two studies also reported that lowering the larval rearing temperature to 18°C instead of 27°C significantly increased the filial infection rates of mosquitoes infected with SLEV.16,23–25 Two other studies26,27 examined the filial infection rates among progeny of individual infected female mosquitoes, and these also varied widely. In summary, experimental studies of VT of flaviviruses in mosquitos have given highly variable results, indicating that there are multiple factors (variables) that can affect the frequency of VT and the resulting filial infection rates in female mosquitoes infected with flaviviruses pathogens. If such variability occurs in laboratory studies that are performed under relatively controlled conditions, then it must be even greater in nature. Consequently, one should interpret the results of such laboratory studies with caution, as they simply demonstrate that VT of these flavivirus pathogens can occur. But the critical question is “does VT occur in nature”? Answering this question is a much more difficult problem, as one would have to collect immature forms (i.e., larvae and pupae) or adult males of the vector species in an area where the virus of interest is endemic or epidemic and to demonstrate that they are infected.
Results of selected published studies of vertical transmission of flaviviruses by mosquitoes
Virus | Mosquito species | Filial infection rate(s)* | Reference |
---|---|---|---|
Yellow fever virus | Aedes aegypti | 1:472 to 1:632 | 14 |
Haemagogus equinus | 1:5,245 | 15 | |
Aedes mascarensis | 1:707 | 14 | |
DENV-1 | Ae. aegypti | < 1:600 to 1:1,543 | 16 |
Aedes albopictus | 1:200 | 16 | |
Ae. albopictus | 1:217 | 17 | |
DENV-2 | Ae. aegypti | < 1:401 to < 1:459 | 16 |
Ae. aegypti | 1:813 to 1:3,042 | 18 | |
Ae. albopictus | 1:408 | 16 | |
DENV-3 | Ae. aegypti | < 1:540 | 16 |
Ae. albopictus | 1:320 | 16 | |
Ae. aegypti | 1:36 | 19 | |
DENV-4 | Ae. aegypti | < 1:1,700 | 16 |
Ae. albopictus | 1:194 | 16 | |
West Nile (Kunjin) virus | Culex tritaeniorhynchus | 1:325 to 1:850 | 20 |
Ae. aegypti | 1:62 to 1:72 | 20 | |
Ae. albopictus | 1:471 | 17 | |
Japanese encephalitis virus | Ae. albopictus | 1:235 to 1:826 | 21 |
Aedes togoi | 1:83 to 1:173 | 21 | |
Ae. albopictus | 1:267 | 17 | |
Culex pipiens | 1:711 | 22 | |
Culex quinquefasciatus | 1:1,336 to 1:6,400 | 22 | |
St. Louis encephalitis virus | Culex tarsalis | < 1:140 | 23 |
Aedes taeniorhynchus | 1:181 | 24 | |
Cx. quinquefasciatus | 1:1,120 | 24 | |
Ae. albopictus | 1:494 to < 1:828 | 25 | |
Zika virus | Ae. aegypti | 1:290 | Present study |
Ae. albopictus | < 1:803 |
DENV = dengue virus.
Reported filial infection rates vary depending on the virus strain and mosquito strain used.
Another potential variable is the presence of ISVs. The earlier experimental studies mentioned above and in Table 1 were performed at a time when most of the mosquito-specific flaviviruses were still unrecognized,8,10 consequently the infection status of the mosquito colonies used, with regard to mosquito-specific viruses, was unknown. Available evidence now indicates that mosquito-specific flaviviruses are common in nature and in laboratory mosquito colonies.8,10 These viruses are also maintained by VT in their insect hosts and at much higher filial infection rates than the flavivirus vertebrate pathogens.8,10 The effect of these ISVs on the vector competence of their mosquito hosts is uncertain and may represent another important variable affecting VT of flavivirus arboviral pathogens, such as ZIKV, DENV, YFV, JEV, SLEV, and WNV.8,10 One potential effect of prior infection of a mosquito with an insect-specific flavivirus is superinfection exclusion (or homologous interference), a process by which cells infected with one virus do not support replication of the same or a similar virus.9 This phenomenon has been observed during infection of both vertebrate and invertebrate hosts with a broad range of viruses, including some of the mosquito-specific flaviviruses.9 Consequently, the absence or presence of mosquito-specific flaviviruses in a laboratory mosquito colony potentially could also alter the VT rate of a flavivirus pathogen in that colony.
In view of the relatively low filial infection rates observed with ZIKV and other flavivirus pathogens (Table 1), one might conclude that VT is of little epidemiologic importance. With the low filial infection rates observed in those experimental studies, mathematical models28,29 predict that flavivirus pathogens such as ZIKV, DENV, YFV, or WNV would survive for only a few generations without horizontal transmission and amplification in a vertebrate. However, VT rates in this range may be sufficient to allow a flavivirus to persist during hot dry periods or cold weather, when adult vectors are absent or in low numbers.29 Many Aedes species, including Ae. aegypti and Ae. albopictus, produce resistant eggs that can survive for months (or longer) in a dried dormant state.30,31 Although adults may not survive a winter or dry season, when favorable environmental conditions return, the eggs hatch and larvae emerge to complete the insect's life cycle and to establish a new generation. As the larvae pass through various developmental stages and grow, the virus also replicates, so that by the time an infected adult female emerges, she is infectious and able to transmit the virus.
Venereal transmission is another mechanism by which a virus can be amplified in a mosquito population. Although male mosquitoes do not take blood, they can acquire virus by VT from an infected female parent. In experimental studies, infected male mosquitoes can transmit virus horizontally to noninfected adult females during mating as well as to her developing oocytes, resulting in infected F1 progeny.7,32
Another mechanism for virus to be maintained in an insect population is the stabilized infection model, as described with Sigma virus (Rhabdoviridae) in Drosophila melanogaster.33 In this condition, the virus is maintained by VT at a high level in nature by relatively few infected females. Stabilized infections have been demonstrated in several Aedes mosquito species with California encephalitis serogroup viruses (Orthobunyavirus: Bunyaviridae).34,35
Because of these alternative methods of virus transmission, the importance of VT should not be discounted, based solely on low filial infection rates observed in experimental laboratory studies.
Knowledge of the transmission mechanisms of arboviruses in their vertebrate and invertebrate hosts continue to evolve. ZIKV was once thought to be transmitted to humans solely by the bite of infected mosquitoes. The recent pandemic in the South Pacific and the Americas has shown that other modes of human infection can occur (venereal, congenital, postpartum, and blood transfusion).1,2 The classical concept that arboviruses are maintained in nature by continual transmission between susceptible vertebrate hosts by hematophagous arthropods is also outdated and incomplete, as alternative mechanisms for virus maintenance within the vector population have been described. ZIKV is probably no exception. As a survival strategy, a successful parasite (in this case an arbovirus) might be expected to have alternative maintenance mechanisms to insure its survival during periods when susceptible vertebrate or arthropod hosts are not available. The alternative maintenance mechanisms (survival strategies) for ZIKV in its mosquito hosts is a neglected area of research, but this information is essential if we want to fully understand the ecology of ZIKV and to eventually control it.
- 3.↑
Lazear HM, Diamond MS, 2016. Zika virus: new clinical syndromes and its emergence in the Western Hemisphere. J Virol 90: 4864–4875.
- 4.↑
Vasilakis N, Weaver SC, 2008. The history and evolution of human dengue emergence. Adv Virus Res 72: 1–76.
- 5.
Monath TP, 2001. Yellow fever: an update. Lancet 1: 11–20.
- 7.↑
Tesh RB, Bolling BG, Beaty BJ, 2016. Role of vertical transmission in arbovirus maintenance and evolution. Gubler DJ, Vasilakis N, eds. Arboviruses: Molecular Biology, Evolution and Control. Norfolk, United Kingdom: Calister Academic Press, 191–218.
- 8.↑
Bolling BG, Weaver SC, Tesh RB, Vasilakis N, 2015. Insect-specific virus discovery: significance for the arbovirus community. Viruses 7: 4911–4928.
- 9.↑
Blitvich BJ, Firth AE, 2015. Insect-specific flaviviruses: a systemic review of their discovery, host range, mode of transmission, superinfection exclusion potential and genomic organization. Viruses 7: 1927–1959.
- 10.↑
Higgs S, 2005. Care, maintenance, and experimental infection of mosquitoes. Marquardt WC, ed. Biology of Disease Vectors, 2nd edition. Burlington, MA: Elsevier, 733–739.
- 11.↑
Tesh RB, 1979. A method for the isolation and identification of dengue viruses, using mosquito cell cultures. Am J Trop Med Hyg 28: 1053–1059.
- 12.↑
Hermance ME, Thangamani S, 2015. Tick saliva enhances Powassan virus transmission to the host, influencing its dissemination and the course of disease. J Virol 89: 7852–7860.
- 13.↑
Lanciotti RS, Kosoy OL, Laven JJ, Velez JO, Lambert AJ, Johnson AJ, Standfield SM, Duffy MR, 2008. Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg Infect Dis 14: 1232–1239.
- 14.↑
Beaty BJ, Tesh RB, Aitken THG, 1980. Transovarial transmission of yellow fever virus in Stegomyia mosquitoes. Am J Trop Med Hyg 29: 125–132.
- 15.↑
Dutary BE, LeDuc JW, 1981. Transovarial transmission of yellow fever virus by a sylvatic vector, Haemagogus equinus. Trans R Soc Trop Med Hyg 75: 128.
- 16.↑
Rosen L, Shroyer DA, Tesh RB, Freier JE, Lien JC, 1983. Transovarial transmission of dengue viruses by mosquitoes: Aedes albopictus and Aedes aegypti. Am J Trop Med Hyg 32: 1108–1119.
- 17.↑
Tesh RB, 1980. Experimental studies on the transovarial transmission of Kunjin and San Angelo viruses in mosquitoes. Am J Trop Med Hyg 29: 657–666.
- 18.↑
Joussett FX, 1981. Geographic Aedes aegypti strains and dengue-2 virus: susceptibility, ability to transmit to vertebrate and transovarial transmission. Ann Virol Inst Pasteur 132: 357–370.
- 19.↑
Joshi V, Mourya DT, Sharma RC, 2002. Persistence of dengue-3 virus through transovarial transmission passage in successive generations of Aedes aegypti mosquitoes. Am J Trop Med Hyg 67: 158–161.
- 20.↑
Baqar S, Hayes CG, Murphy JR, Watts DM, 1993. Vertical transmission of West Nile virus by Culex and Aedes species mosquitoes. Am J Trop Med Hyg 48: 757–762.
- 21.↑
Rosen L, Tesh RB, Lien JC, Cross JH, 1978. Transovarial transmission of Japanese encephalitis virus by mosquitoes. Science 199: 909–911.
- 22.↑
Rosen L, Lien JC, Shroyer DA, Baker RH, Lu LC, 1989. Experimental vertical transmission of Japanese encephalitis virus by Culex tritaeniorhynchus and other mosquitoes. Am J Trop Med Hyg 40: 548–556.
- 23.↑
Hardy JL, Rosen L, Reeves WC, Scrivani RP, Presser SB, 1984. Experimental transovarial transmission of St. Louis encephalitis virus by Culex and Aedes mosquitoes. Am J Trop Med Hyg 33: 166–175.
- 24.↑
Nayar JK, Rosen L, Knight JW, 1986. Experimental vertical transmission of Saint Louis encephalitis virus by Florida mosquitoes. Am J Trop Med Hyg 35: 1296–1301.
- 25.↑
Hardy JL, Rosen L, Kramer LD, Presser SB, Shroyer DA, Turell MJ, 1980. Effect of rearing temperature on transovarial transmission of St. Louis encephalitis virus in mosquitoes. Am J Trop Med Hyg 29: 963–968.
- 26.↑
Freier JE, Rosen L, 1988. Vertical transmission of dengue viruses by Aedes mediovittatus. Am J Trop Med Hyg 39: 218–222.
- 27.↑
Shroyer DA, 1990. Vertical maintenance of dengue-1 virus in sequential generations of Aedes albopictus. J Am Mosq Control Assoc 6: 312–314.
- 28.↑
Fine PE, 1975. Vectors and vertical transmission: an epidemiological perspective. Ann N Y Acad Sci 266: 173–194.
- 29.↑
Adams B, Boots M, 2010. How important is vertical transmission in mosquitoes for the persistence of dengue? Insights from a mathematical model. Epidemics 2: 1–10.
- 30.↑
Christophers SR, 1960. Aedes aegypti (L); The Yellow Fever Mosquito. Its Life History, Bionomics and Structure. Cambridge, United Kingdom: Cambridge University Press.
- 31.↑
Estrado-Franco JG, Craig GB Jr, 1995. Biology, Disease Relationships, and Control of Aedes albopictus. Technical Paper 42. Washington, DC: Pan American Health Organization.
- 32.↑
Thompson WH, Beaty BJ, 1977. Venereal transmission of LaCrosse virus from male to female Aedes triseriatus. Am J Trop Med Hyg 27: 187–196.
- 33.↑
Seecof R, 1968. The sigma virus of Drosophila melanogaster. Curr Top Microbiol Immunol 42: 59–93.
- 34.↑
Tesh RB, Shroyer DA, 1980. The mechanism of arbovirus transovarial transmission in mosquitoes: San Angelo virus in Aedes albopictus. Am J Trop Med Hyg 29: 1394–1404.
- 35.↑
Turell MJ, Hardy JL, Reeves WC, 1982. Stabilized infection of California encephalitis virus in Aedes dorsalis, and its implications for viral maintenance in nature. Am J Trop Med Hyg 31: 1252–1259.